A medical classic the day it was published, Pharmageddon is a must-read for anyone in the healthcare world and anyone who plans to need healthcare in the future — in short, everyone.— Amazon review
Toronto, ON (PRWEB) February 28, 2012
Dr. Healy's new book Pharmageddon is the story of a tragedy. Key messages in the book include:
US life expectancy drops
Reversing the trend of the past century, life expectancy in the US has already dropped compared to other advanced countries. “We are in a world where increasingly we need protection from the latest miracle cure to ensure we do not die prematurely,” says Dr. Healy.
Lifestyle drugs dominate
The global market for pharmaceuticals is US$900 billion, but apart from cancer drugs, few new drugs target disease. The bestsellers are “lifestyle” or “risk management” drugs: antidepressants and other psychotropic drugs ($60 billion), cholesterol-lowering statins ($34 billion), blood sugar-lowering hypoglycemics ($24 billion), acid reflux drugs ($26 billion), and treatments for osteoporosis and sexual ”dysfunction.”
Drugs are approved based on incomplete data, and the human consequences are severe
Drug side effects range from discomfort through emotional problems to death. Only 1 in 7 new drugs are superior to existing ones. Not realizing this, millions take the 6 in 7 drugs that aren't, even though they have not been properly tested for risks of harm, often with grave consequences. At least 1.5 million US hospitalizations a year and about 129,000 hospital deaths are caused by serious drug reactions. Yet, fewer than 5% of serious side effects are even reported. Adverse side effects reported by patients and doctors are discounted as “anecdotal”. As a result many are dying unnecessarily from heart attacks, suicide, homicide and strokes.
The financial burden of drug effects is enormous
Health care costs are running dangerously high — close to 20% of US GDP — threatening to derail both the US and the global economy. Drugs are one of the biggest drivers of these costs, directly accounting for up to 20% of health insurers’ costs. The direct costs of treating adverse drug events are estimated to be US $5 billion per year, with US $100 billion in indirect costs. Adverse drug events are currently the fourth leading cause of death in the US and Europe and the leading cause of death within the mental health domain. “This is where any ideas of universal health care will founder,” says Dr Healy.
Stockholm syndrome: Doctors are being held captive by drug companies
How did the drug companies capture doctors and medical care? Dr. Healy draws back the curtain to expose the secrets that enable them to circumvent protections, such as controlled trials, evidence-based medicine and regulatory approvals. He reveals the role of medical ghostwriters in supporting “off-label” prescribing and criticizes organized medicine for failing patients. Dr. Healy also demonstrates how statistics are manipulated to hide unwanted outcomes and inconvenient deaths.
What can be done?
Dr. Healy looks at the larger issues that have shaped the current sickness infecting health care and how we might come to grips with and treat this severe disorder.
What he also offers is a solution — RxISK.org, the first free website (not sponsored by big pharma or advertising) for patients and their doctors to research, and more importantly, easily report drug side effects. The website will also offer patients a medical timeline chart that captures essential information on their symptoms that will enable them to have a more informed discussion with their doctors about the prescription drugs they are taking and their possible consequences.
Dr. Healy will be in North America March 4-24 (New York, Toronto, Los Angeles), lecturing at medical schools, and promoting Pharmageddon and RxISK.org.
ABOUT THE AUTHOR
Dr. David Healy studied medicine in Dublin and Cambridge England. Currently a Professor of Psychological Medicine at the University of Wales, he is the author of 16 books, including The Antidepressant Era and The Creation of Psychopharmacology from Harvard U Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York U Press.
Dr. Healy is a founder and Chief Executive Officer of Data Based Medicine Limited, which operates through its website RxISK.org, dedicated to "making medicines safer for all of us" through online direct-patient reporting of drug effects. He also publishes through his blog DavidHealy.org and on Twitter @DrDavidHealy.
University of California Press
To review an advance of PHARMAGEDDON, or schedule an interview with Dr. Healy please contact: